Crestline Management, LP
- SEC CIK
- 0001536054
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 3
- 0 vs. Q1 2026
- Portfolio value
- $53.5M
- +$7.21M (+15.6%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DNLIDenali Therapeutics Inc. | COM | 1,910,732 | $49.1M | 91.9% | −300,000−13.6% | Reduced | History |
| SANASana Biotechnology, Inc. | COM | 755,736 | $2.64M | 4.9% | 00.0% | Unchanged | History |
| EGHT8X8 Inc | COM | 990,850 | $1.69M | 3.2% | 00.0% | Unchanged | History |